ACUTA CAPITAL PARTNERS, LLC
REDWOOD CITY, CA · CIK 1582844 · 13F filing filed 2022-08-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityACUTA CAPITAL PARTNERS, LLC (US)
- Kindhedge funds, futures
- Others nearbyRedwood City, CA
- FamilyACUTA CAPITAL PARTNERS, LLC · 2 related pages
$178.8m
reported value
-14.9% vs Q1 2022
41positions
60.5%in top 10
12 new
12 added
10 reduced
9 sold out
vs Q1 2022
Options: 2 call positions ($694.0k notional), 0 put positions (— notional) – listed below, not included above.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APELLIS PHARMACEUTICALS INC APLS | $25.1m14.01% | Unchanged |
| AADI BIOSCIENCE INC WHWK | $18.8m10.54% | Unchanged |
| VISTAGEN THERAPEUTICS INC VTGN | $10.0m5.59% | Reduced -374.8k |
| KURA ONCOLOGY INC KURA | $9.8m5.50% | Added +62.5k |
| BCLS ACQUISITION CORP COM CL A | $8.3m4.67% | Unchanged |
| XENON PHARMACEUTICALS INC XENE | $8.3m4.64% | Added +47.5k |
| BELLUS HEALTH INC NEW BLU | $7.5m4.22% | Unchanged |
| CELLDEX THERAPEUTICS INC NEW CLDX | $7.2m4.03% | Reduced -55.7k |
| RELMADA THERAPEUTICS INC RLMD | $6.7m3.74% | Added +10.5k |
| MIRATI THERAPEUTICS INC MRTX | $6.3m3.55% | Added +42.0k |
| JIYA ACQUISITION CORP COM CL A | $5.6m3.11% | Unchanged |
| IVERIC BIO INC OPHT | $5.4m3.03% | Added +24.1k |
| ROCHE GS COM | $5.3m2.99% | New |
| ARCUS BIOSCIENCES INC RCUS | $4.2m2.37% | New |
| SYNDAX PHARMACEUTICALS INC SNDX | $3.9m2.21% | Reduced -1.1k |
| HEALTH SCIENCES ACQ CORP 2 OBIO | $3.9m2.19% | Unchanged |
| MERUS N V MRUS | $3.5m1.95% | Reduced -81.5k |
| PRECISION BIOSCIENCES INC COM | $3.3m1.83% | New |
| UNITED THERAPEUTICS CORP DEL UTHR | $3.1m1.71% | New |
| HORIZON THERAPEUTICS PUB L HZNP | $2.9m1.60% | Added +2.7k |
| MILESTONE PHARMACEUTICALS IN MIST | $2.8m1.57% | Added +77.2k |
| VIRIDIAN THERAPEUTICS INC VRDN | $2.7m1.51% | Reduced -106.0k |
| ACLARIS THERAPEUTICS INC ACRS | $2.7m1.51% | Reduced -24.8k |
| GH RESEARCH PLC GHRS | $2.4m1.36% | Reduced -176.4k |
| EYEPOINT PHARMACEUTICALS INC EYPT | $2.4m1.34% | Reduced -4.5k |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $2.2m1.22% | Reduced -20.6k |
| PMV PHARMACEUTICALS INC PMVP | $2.2m1.22% | Added +17.0k |
| REZOLUTE INC RZLT | $2.1m1.17% | New |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $1.7m0.95% | Added +35.5k |
| PYXIS ONCOLOGY INC PYXS | $1.5m0.86% | Added +445.1k |
| VENTYX BIOSCIENCES INC VTYX | $1.5m0.83% | Added +51.1k |
| ENANTA PHARMACEUTICALS INC ENTA | $1.3m0.73% | Added +25.2k |
| ITEOS THERAPEUTICS INC ITOS | $1.3m0.71% | New |
| ACADIA PHARMACEUTICALS INC ACAD | $1.0m0.56% | New |
| FULCRUM THERAPEUTICS INC FULC | $980.0k0.55% | Unchanged |
| GOSSAMER BIO INC GOSS | $268.0k0.15% | New |
| VERASTEM INC COM | $232.0k0.13% | Reduced -797.0k |
| SPRINGWORKS THERAPEUTICS INC SWTX | $123.0k0.07% | New |
| TREVI THERAPEUTICS INC TRVI | $98.0k0.05% | New |
| OCULAR THERAPEUTIX INC OCUL | $53.0k0.03% | New |
| NUVATION BIO INC NUVB.WS | $25.0k0.01% | New |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| JOUNCE THERAPEUTICS INC JNCE | $5.5m813.5k shares |
| AVADEL PHARMACEUTICALS PLC | $4.0m580.0k shares |
| HARPOON THERAPEUTICS INC | $2.5m497.5k shares |
| ATHIRA PHARMA INC | $1.9m140.0k shares |
| MOLECULAR TEMPLATES INC | $1.1m307.1k shares |
| DICE THERAPEUTICS INC | $717.0k37.5k shares |
| IMMUNOGEN INC IMGN | $262.0k55.0k shares |
| SEELOS THERAPEUTICS INC | $248.0k295.9k shares |
| NUVATION BIO INC NUVB | $69.0k90.8k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| AC IMMUNE SA Call | $354.0k100.0k shares | New |
| ATHIRA PHARMA INC Call | $340.0k100.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| AADI BIOSCIENCE INC WHWK · 13D · filed 2026-05-18 | 9.0%≈ $22.2m |